Literature DB >> 3982800

Clinical evaluation of fibronectin eyedrops on epithelial disorders after herpetic keratitis.

T Nishida, S Nakagawa, R Manabe.   

Abstract

The clinical efficacy was investigated of fibronectin eyedrops on the nonhealing corneal epithelial defect after herpetic keratitis. Fibronectin eyedrops were prepared from the patient's own blood plasma by an affinity chromatography using gelatin-coupled agarose gel and by gel filtration technique. Twenty eyes with metaherpetic trophic ulcer with persistent epithelial defect that had not responded to conventional therapy were treated by the instillation of fibronectin eyedrops 6 times a day. The mean +/- standard deviation duration of epithelial defect was 61.5 +/- 66.1 days. The epithelial defects healed within 15.6 +/- 12.4 days. These results suggest that fibronectin eyedrops are a possible effective therapeutic approach in nonhealing corneal epithelial defect after herpetic keratitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3982800     DOI: 10.1016/s0161-6420(85)34050-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  6 in total

1.  Differential contributions of impaired corneal sensitivity and reduced tear secretion to corneal epithelial disorders.

Authors:  Teruo Nishida; Tai-Ichiro Chikama; Mitsuru Sawa; Kazunori Miyata; Takaaki Matsui; Kyoko Shigeta
Journal:  Jpn J Ophthalmol       Date:  2011-11-11       Impact factor: 2.447

Review 2.  The role of fibronectin in corneal wound healing explored by a physician-scientist.

Authors:  Teruo Nishida
Journal:  Jpn J Ophthalmol       Date:  2012-07-27       Impact factor: 2.447

3.  Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation.

Authors:  P Prabhasawat; N Tesavibul; W Komolsuradej
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

Review 4.  Fibronectin and the critically ill patient: current status.

Authors:  T M Saba; J L Kiener; J M Holman
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

5.  Topical fibronectin therapy of persistent corneal epithelial defects. Fibronectin Study Group.

Authors:  J P McCulley; B Horowitz; Z M Husseini; M Horowitz
Journal:  Trans Am Ophthalmol Soc       Date:  1993

6.  Fibronectin receptors of human keratinocytes and their expression during cell culture.

Authors:  K Toda; T L Tuan; P J Brown; F Grinnell
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.